FDA marketing clearance for Cell Robotics:
This article was originally published in Clinica
Executive Summary
Cell Robotics International has received FDA approval to market its Lasette laser finger perforator. The device uses a single pulse of laser light to produce a small hold in the finger for capillary blood collection and replaces the traditional steel lancet. The laser is the first to be given clearance for use on all adults in clinical settings including diabetics, the company claimed.